These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20084989)

  • 61. Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.
    Soroka SD; Granade TC; Candal D; Parekh BS
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):918-21. PubMed ID: 16085908
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.
    Alary M; Joly JR; Parent R; Fauvel M; Dionne M
    CMAJ; 1994 Oct; 151(7):975-81. PubMed ID: 7922933
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Incidence of HIV-1 infection in adults and socio-demographic characteristics of seroconverters in a rural population in Uganda: 1990-1994.
    Kengeya-Kayondo JF; Kamali A; Nunn AJ; Ruberantwari A; Wagner HU; Mulder DW
    Int J Epidemiol; 1996 Oct; 25(5):1077-82. PubMed ID: 8921497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi.
    Willerford DM; Bwayo JJ; Hensel M; Emonyi W; Plummer FA; Ngugi EN; Nagelkerke N; Gallatin WM; Kreiss J
    J Infect Dis; 1993 Jun; 167(6):1414-7. PubMed ID: 8501333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion.
    Schwarcz S; Kellogg T; McFarland W; Louie B; Kohn R; Busch M; Katz M; Bolan G; Klausner J; Weinstock H
    Am J Epidemiol; 2001 May; 153(10):925-34. PubMed ID: 11384946
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
    Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
    AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Uptake and linkage into care over one year of providing HIV testing and counselling through community and health facility testing modalities in urban informal settlement of Kibera, Nairobi Kenya.
    Muhula S; Memiah P; Mbau L; Oruko H; Baker B; Ikiara G; Mungai M; Ndirangu M; Achwoka D; Ilako F
    BMC Public Health; 2016 May; 16():373. PubMed ID: 27142727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Beatrice S; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    Am J Public Health; 2005 Aug; 95(8):1439-44. PubMed ID: 15985649
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002.
    de Freitas Oliveira CA; Ueda M; Yamashiro R; Rodrigues R; Sheppard HW; de Macedo Brígido LF
    J Clin Microbiol; 2005 Mar; 43(3):1439-42. PubMed ID: 15750127
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults.
    Kirkpatrick AR; Unsal AB; Blankson JN; Moore RD; Quinn TC; Hadigan C; Laeyendecker O
    Pediatr Infect Dis J; 2017 Nov; 36(11):1064-1066. PubMed ID: 28650937
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Using VCT statistics from Kenya in understanding the association between gender and HIV.
    Otwombe KN; Ndindi P; Ajema C; Wanyungu J
    SAHARA J; 2007 Nov; 4(3):707-10. PubMed ID: 18185897
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
    Karita E; Price M; Hunter E; Chomba E; Allen S; Fei L; Kamali A; Sanders EJ; Anzala O; Katende M; Ketter N;
    AIDS; 2007 Feb; 21(4):403-8. PubMed ID: 17301558
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Establishment of the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion (STARHS) strategy in the city of São Paulo, Brazil.
    Kallas EG; Bassichetto KC; Oliveira SM; Goldenberg I; Bortoloto R; Moreno DM; Kanashiro C; Chaves MM; Sucupira MC; Diniz A; Mesquita FC
    Braz J Infect Dis; 2004 Dec; 8(6):399-406. PubMed ID: 15880230
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Continuous quality improvement intervention for adolescent and young adult HIV testing services in Kenya improves HIV knowledge.
    Wagner AD; Mugo C; Bluemer-Miroite S; Mutiti PM; Wamalwa DC; Bukusi D; Neary J; Njuguna IN; O'Malley G; John-Stewart GC; Slyker JA; Kohler PK
    AIDS; 2017 Jul; 31 Suppl 3(Suppl 3):S243-S252. PubMed ID: 28665882
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estimating HIV Incidence Using a Cross-Sectional Survey: Comparison of Three Approaches in a Hyperendemic Setting, Ndhiwa Subcounty, Kenya, 2012.
    Blaizot S; Kim AA; Zeh C; Riche B; Maman D; De Cock KM; Etard JF; Ecochard R
    AIDS Res Hum Retroviruses; 2017 May; 33(5):472-481. PubMed ID: 27824254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing.
    Kellogg TA; Loeb L; Dilley J; Adler B; Louie BT; McFarland W
    J Acquir Immune Defic Syndr; 2005 May; 39(1):112-20. PubMed ID: 15851921
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recent HIV type 1 infection among participants in a same-day mobile testing pilot study in Zimbabwe.
    Truong HM; Fritz K; McFarland W; Hartogensis W; Fiamma A; Coates TJ; Morin SF
    AIDS Res Hum Retroviruses; 2011 Jun; 27(6):593-5. PubMed ID: 21087196
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Standardization and monitoring of laboratory performance and quality assurance by use of the less-sensitive HIV incidence assay: seven years of results.
    Mei JV; Kennedy M; Linley L; Hanson D; Schiffer J; Ethridge S; Branson B
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):482-8. PubMed ID: 21857352
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HIV seroincidence estimates among at-risk populations in Buenos Aires and Montevideo: use of the serologic testing algorithm for recent HIV seroconversion.
    Vignoles M; Avila MM; Osimani ML; de Los Angeles Pando M; Rossi D; Sheppard H; Sosa-Estani S; Benetucci J; Maulen S; Chiparelli H; Russi J; Sánchez JL; Montano SM; Martínez-Peralta L; Weissenbacher M
    J Acquir Immune Defic Syndr; 2006 Aug; 42(4):494-500. PubMed ID: 16810116
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praço Onze Study Group.
    Schechter M; do Lago RF; de Melo MF; Sheppard HW; Guimarães NC; Moreira RI; Faulhaber JC; Batista S; Harrison LH
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):175-7. PubMed ID: 10935694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.